Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series

American Psychiatric Association, 1994 American Psychiatric Association (1998). Practice guideline for the treatment of patients with panic disorder. American Journal of Psychiatry, 155, 1–34. Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (in press). A randomized controlled trial of cognitive-behavioral treatment vs. imipramine and their combination for panic disorder: primary outcome results. Journal of the American Medical Association. Beck, 1990 Brown, 1994 Bruce, 1995, Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder, American Journal of Psychiatry, 152, 1156, 10.1176/ajp.152.8.1156 Chambless, 1985, The Mobility Inventory for agoraphobia, Behaviour Research and Therapy, 23, 35, 10.1016/0005-7967(85)90140-8 Clark, 1994, A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder, British Journal of Psychiatry, 164, 759, 10.1192/bjp.164.6.759 Clum, 1993, A meta-analysis of treatments for panic disorder, Journal of Consulting and Clinical Psychology, 61, 317, 10.1037/0022-006X.61.2.317 Coplan, 1996, An algorithm-oriented treatment approach for panic disorder, Psychiatric Annals, 26, 192, 10.3928/0048-5713-19960401-09 Coupland, 1996, Serotonin reuptake inhibitor withdrawal, Journal of Clinical Psychopharmacology, 16, 356, 10.1097/00004714-199610000-00003 Gould, 1995, A meta-analysis of treatment outcome for panic disorder, Clinical Psychology Review, 15, 819, 10.1016/0272-7358(95)00048-8 Hegel, 1994, Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder, Behavior Therapy, 25, 183, 10.1016/S0005-7894(05)80282-5 Jobson, 1995, Algorithm for the treatment of panic disorder with agoraphobia, Psychopharmocology Bulletin, 31, 457 Klosko, 1990, Comparison of alprazolam and behavior therapy in the treatment of panic disorder, Journal of Consulting and Clinical Psychology, 58, 77, 10.1037/0022-006X.58.1.77 Lydiard, 1998, Efficacy studies of paroxetine in panic disorder, Psychopharmacology Bulletin, 34, 175 Marks, 1979, Brief standard self-rating for phobic patients, Behaviour Research and Therapy, 17, 263, 10.1016/0005-7967(79)90041-X Marks, 1993, Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto, British Journal of Psychiatry, 162, 776, 10.1192/bjp.162.6.776 Otto, 1996 Otto, 1995 Otto, M. W., Pollack, M. H., & Maki, K. M. (in press). Empirically-supported treatment for panic disorder: costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology. Otto, 1993, Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavior therapy for patients with panic disorder, American Journal of Psychiatry, 150, 1485, 10.1176/ajp.150.10.1485 Otto, 1999, The impact of treatment on anxiety sensitivity, 321 Otto, 1996, Maintenance of remission following cognitive-behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment, Behavior Therapy, 27, 473, 10.1016/S0005-7894(96)80028-1 Otto, 1995, Cognitive-behavior therapy and the longitudinal course of panic disorder, Psychiatric Clinics of North America, 18, 803, 10.1016/S0193-953X(18)30024-8 Penava, 1998, Rate of improvement during cognitive-behavioral group treatment for panic disorder, Behaviour Research and Therapy, 36, 665, 10.1016/S0005-7967(98)00035-7 Peterson, 1987 Pollack, 1995, The longitudinal course and outcome of panic disorder, Psychiatric Clinics of North America, 18, 785, 10.1016/S0193-953X(18)30023-6 Price, 1996, A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal, British Journal of Clinical Pharmacology, 42, 757, 10.1046/j.1365-2125.1996.00498.x Rosenbaum, 1998, Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial, Biological Psychiatry, 44, 77, 10.1016/S0006-3223(98)00126-7 Sharp, 1996, Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia, Journal of Anxiety Disorders, 10, 219, 10.1016/0887-6185(96)00008-4 Speigel, 1994, Does cognitive behavioral therapy assist slow taper alprazolam discontinuation in panic disorder, American Journal of Psychiatry, 151, 876, 10.1176/ajp.151.6.876